TY - JOUR
T1 - Practical method of adaptive radiotherapy for prostate cancer using real-time electromagnetic tracking
AU - Olsen, Jeffrey R.
AU - Noel, Camille E.
AU - Baker, Kenneth
AU - Santanam, Lakshmi
AU - Michalski, Jeff M.
AU - Parikh, Parag J.
N1 - Funding Information:
Conflict of interest: Research interface provided by Calypso Medical Technologies. Dr. Parikh receives research funding from Calypso Medical Technologies .
Funding Information:
Supported in part by National Cancer Institute Grant R01CA134541 .
PY - 2012/4/1
Y1 - 2012/4/1
N2 - Purpose: We have created an automated process using real-time tracking data to evaluate the adequacy of planning target volume (PTV) margins in prostate cancer, allowing a process of adaptive radiotherapy with minimal physician workload. We present an analysis of PTV adequacy and a proposed adaptive process. Methods and Materials: Tracking data were analyzed for 15 patients who underwent step-and-shoot multi-leaf collimation (SMLC) intensity-modulated radiation therapy (IMRT) with uniform 5-mm PTV margins for prostate cancer using the Calypso® Localization System. Additional plans were generated with 0- and 3-mm margins. A custom software application using the planned dose distribution and structure location from computed tomography (CT) simulation was developed to evaluate the dosimetric impact to the target due to motion. The dose delivered to the prostate was calculated for the initial three, five, and 10 fractions, and for the entire treatment. Treatment was accepted as adequate if the minimum delivered prostate dose (D min) was at least 98% of the planned D min. Results: For 0-, 3-, and 5-mm PTV margins, adequate treatment was obtained in 3 of 15, 12 of 15, and 15 of 15 patients, and the delivered D min ranged from 78% to 99%, 96% to 100%, and 99% to 100% of the planned D min. Changes in D min did not correlate with magnitude of prostate motion. Treatment adequacy during the first 10 fractions predicted sufficient dose delivery for the entire treatment for all patients and margins. Conclusions: Our adaptive process successfully used real-time tracking data to predict the need for PTV modifications, without the added burden of physician contouring and image analysis. Our methods are applicable to other uses of real-time tracking, including hypofractionated treatment.
AB - Purpose: We have created an automated process using real-time tracking data to evaluate the adequacy of planning target volume (PTV) margins in prostate cancer, allowing a process of adaptive radiotherapy with minimal physician workload. We present an analysis of PTV adequacy and a proposed adaptive process. Methods and Materials: Tracking data were analyzed for 15 patients who underwent step-and-shoot multi-leaf collimation (SMLC) intensity-modulated radiation therapy (IMRT) with uniform 5-mm PTV margins for prostate cancer using the Calypso® Localization System. Additional plans were generated with 0- and 3-mm margins. A custom software application using the planned dose distribution and structure location from computed tomography (CT) simulation was developed to evaluate the dosimetric impact to the target due to motion. The dose delivered to the prostate was calculated for the initial three, five, and 10 fractions, and for the entire treatment. Treatment was accepted as adequate if the minimum delivered prostate dose (D min) was at least 98% of the planned D min. Results: For 0-, 3-, and 5-mm PTV margins, adequate treatment was obtained in 3 of 15, 12 of 15, and 15 of 15 patients, and the delivered D min ranged from 78% to 99%, 96% to 100%, and 99% to 100% of the planned D min. Changes in D min did not correlate with magnitude of prostate motion. Treatment adequacy during the first 10 fractions predicted sufficient dose delivery for the entire treatment for all patients and margins. Conclusions: Our adaptive process successfully used real-time tracking data to predict the need for PTV modifications, without the added burden of physician contouring and image analysis. Our methods are applicable to other uses of real-time tracking, including hypofractionated treatment.
KW - Adaptive
KW - Cancer
KW - Intrafraction
KW - Prostate
KW - Radiotherapy
UR - http://www.scopus.com/inward/record.url?scp=84858705381&partnerID=8YFLogxK
U2 - 10.1016/j.ijrobp.2011.01.040
DO - 10.1016/j.ijrobp.2011.01.040
M3 - Article
C2 - 21470786
AN - SCOPUS:84858705381
SN - 0360-3016
VL - 82
SP - 1903
EP - 1911
JO - International Journal of Radiation Oncology Biology Physics
JF - International Journal of Radiation Oncology Biology Physics
IS - 5
ER -